Therefore, the co-occurrence of the two ligand–receptor pairs (LGALS9-SLC1A5 and SPP1-PTGER4) was stable and the elevated expressions were associated with poor patient outcome in HCC. The gene discussed is SLC1A5; the disease is hepatocellular carcinoma.